• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Molecular weight of undegraded plasma factor V.

作者信息

Mann K G, Nesheim M E, Tracy P B

出版信息

Biochemistry. 1981 Jan 6;20(1):28-33. doi: 10.1021/bi00504a005.

DOI:10.1021/bi00504a005
PMID:7470475
Abstract

The molecular size and immunochemical properties of the unfractionated factor V present in plasma collected by venipuncture into a broad-spectrum anticoagulant and platelet-inhibited mixture were compared with those reported for the isolated, single-chain factor V molecular of 330 000 daltons. The anticoagulant--plasma mixture included 0.28% trisodium citrate, 2 mM benzamidine hydrochloride, 0.02% soybean trypsin inhibitor, 2.0 mM diisopropyl phosphorofluoridate, 10 microM dansylarginine N-(3-ethyl-1,5-pentanediyl)amide, and 5 microM prostaglandin E1. The Stokes radius of unfractionated factor V present in highly inhibited plasma (93 A) is virtually identical with the Stokes radius predicted from the hydrodynamic data for the highly asymmetric, single-chain factor V molecule (91 A). With an expression which relates the Stokes radius and the sedimentation coefficient to the molecular weight of hydrodynamic units, the molecular weight obtained for factor V, using gel filtration data, is 336 000, in good agreement with the molecular weight determined from the sedimentation equilibrium, 330 000. In contrast, the Stokes radius for the factor Va present in serum is significantly smaller (50.5 A) and equivalent to the Stokes radius obtained upon activation of isolated factor V with thrombin. Immunochemical comparisons of the factor V present in the inhibited plasma and isolated factor V were conducted by using burro antibovine factor V antibody and the technique of immunoelectrophoresis. The factor V antigen present in both sources is immunochemically identical, as is the electrophoretic mobility of both factor V preparations. These data serve to justify the conclusion that the factor V isolated as a single-chain 330 000-dalton molecule corresponds to the factor V circulating in plasma.

摘要

相似文献

1
Molecular weight of undegraded plasma factor V.
Biochemistry. 1981 Jan 6;20(1):28-33. doi: 10.1021/bi00504a005.
2
Isolation and characterization of single chain bovine factor V.
J Biol Chem. 1979 Jan 25;254(2):508-17.
3
Immunochemical studies of factor V of bovine platelets.牛血小板凝血因子V的免疫化学研究。
Eur J Biochem. 1981 Nov;120(2):235-41. doi: 10.1111/j.1432-1033.1981.tb05694.x.
4
Immunochemical studies on factor V.关于凝血因子V的免疫化学研究。
Eur J Biochem. 1975 Oct 1;58(1):213-22. doi: 10.1111/j.1432-1033.1975.tb02366.x.
5
Coagulation factor V exists uncomplexed in bovine plasma.凝血因子V以未复合的形式存在于牛血浆中。
Biochim Biophys Acta. 1982 Feb 25;714(3):524-9. doi: 10.1016/0304-4165(82)90163-5.
6
Isolation and partial characterization of human factor V.人凝血因子V的分离及部分特性鉴定
Biochim Biophys Acta. 1979 May 23;578(1):23-30. doi: 10.1016/0005-2795(79)90108-9.
7
Human coagluation factor V purification and thrombin-catalyzed activation.人凝血因子V的纯化及凝血酶催化激活
J Clin Invest. 1980 Sep;66(3):583-91. doi: 10.1172/JCI109890.
8
Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.血小板抗肝素活性。从凝血酶聚集的洗涤人血小板中释放的血小板因子4的分离与特性鉴定,以及其亚基解离和膜结合抗肝素活性的分离。
Biochim Biophys Acta. 1975 Feb 27;379(2):370-84.
9
Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.抗血友病因子浓缩物中蛋白酶的特性:通过高压凝胶渗透色谱法评估对凝血因子VIII:血管性血友病因子的影响。
J Lab Clin Med. 1984 Nov;104(5):816-28.
10
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.人凝血因子V缺乏的异质性。抗原阳性变体存在的证据。
J Clin Invest. 1983 Aug;72(2):493-503. doi: 10.1172/jci110997.

引用本文的文献

1
Cryo-EM structures of human coagulation factors V and Va.人凝血因子 V 和 Va 的冷冻电镜结构。
Blood. 2021 Jun 3;137(22):3137-3144. doi: 10.1182/blood.2021010684.
2
The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin.凝血酶原中亮氨酸480和谷氨酰胺481氨基酸的双重调节作用
J Biol Chem. 2016 Jan 22;291(4):1565-1581. doi: 10.1074/jbc.M115.691956. Epub 2015 Nov 24.
3
Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.凝血因子 V 氨基酸区域 1000-1008 是促凝活性出现的动态调节因子。
J Biol Chem. 2013 Dec 27;288(52):37026-38. doi: 10.1074/jbc.M113.462374. Epub 2013 Oct 31.
4
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.凝血因子 V(A2440G) 通过 TFPIα 导致东德克萨斯出血性疾病。
J Clin Invest. 2013 Sep;123(9):3777-87. doi: 10.1172/JCI69091. Epub 2013 Aug 27.
5
Coagulation procofactor activation by factor XIa.凝血因子 XIa 对凝血酶原激活物的激活作用。
J Thromb Haemost. 2010 Jul;8(7):1532-9. doi: 10.1111/j.1538-7836.2010.03899.x. Epub 2010 May 4.
6
Assembly of the prothrombinase complex.凝血酶原酶复合物的组装。
Biophys J. 1982 Jan;37(1):106-7. doi: 10.1016/S0006-3495(82)84624-9.
7
Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency.导致因子V缺乏的3种因子V突变(R2174L、V1813M和一个5碱基对缺失)的分子特征分析
Int J Hematol. 2007 Dec;86(5):407-13. doi: 10.1007/BF02983997.
8
Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.凝血酶原酶复合物在血小板表面的组装是通过因子Va的74,000道尔顿组分介导的。
Proc Natl Acad Sci U S A. 1983 Apr;80(8):2380-4. doi: 10.1073/pnas.80.8.2380.
9
Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.内源性和外源性凝血过程中因子V的激活。肝素、水蛭素和D-苯丙氨酸-脯氨酸-精氨酸-氯甲基酮的抑制作用。
Biochem J. 1990 Dec 1;272(2):399-406. doi: 10.1042/bj2720399.